Stocklytics Platform
Asset logo for symbol HLVX
HilleVax
HLVX48
$1.87arrow_drop_up1.35%$0.02
Penny Stock
Asset logo for symbol HLVX
HLVX48

$1.87

arrow_drop_up1.35%
Key Stats
Open$1.83
Prev. Close$1.83
EPS-3.30
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$85.27M
PE Ratio-
LOWHIGH
Day Range1.82
1.89
52 Week Range1.55
20.22
Ratios
Revenue-
EBITDA Margin %-
EPS-3.30
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.92%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

HLVXarrow_drop_up0.27%
US Healthcare Sectorarrow_drop_down0.02%
US Marketarrow_drop_up0.60%
warning
HLVX / Market
HLVX lose to the US Market which returned 0.60% over the last twenty four hours.
check_circle
HLVX / Healthcare Sector
HLVX exceeded the US Healthcare sector which returned -0.02% over the last twenty four hours.

HilleVax (HLVX) Statistics

HilleVax, Inc., commonly referred to as HLVX, is a leading biotechnology company that specializes in the development and production of vaccines. With a strong focus on research and development, HilleVax is at the forefront of advancements in vaccine technology. The company has a diverse portfolio of products targeting various infectious diseases, including influenza, hepatitis, and meningitis. HLVX is committed to improving global health by providing safe and effective vaccines to people around the world.

When analyzing HilleVax's valuation metrics, it is important to consider several factors. The company's stock performance versus the sector can provide valuable insights into its relative strength and competitiveness. Additionally, HLVX's revenue per share is a useful indicator of its financial performance. This metric measures the amount of revenue generated by the company for each outstanding share of its stock.

add HilleVax to watchlist

Keep an eye on HilleVax

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has HilleVax (HLVX) stock's performance compared to its sector and the market over the past year?

Over the past year, HilleVax (HLVX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 27.70%, HilleVax has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 49.59%, it has fallen short of the market average. This comparison highlights HilleVax's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of HilleVax (HLVX) stock?

The PE ratio for HilleVax (HLVX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

help
What is the EPS of HilleVax (HLVX) stock?

The Earnings Per Share (EPS) for HilleVax (HLVX), calculated on a diluted basis, is -$3.3. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of HilleVax (HLVX) stock?

The operating margin for HilleVax (HLVX) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of HilleVax (HLVX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of HilleVax (HLVX) is -$137.52M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does HilleVax (HLVX) have?

HilleVax (HLVX) has a total debt of $51.31M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$89.77M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level